Clinical Trial Update: A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for TCP-25 Gel in patients with epidermolysis bullosa, including dystrophic and junctional forms. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa
• Epidermolysis Bullosa
• Junctional Epidermolysis Bullosa

Drugs mentioned

• TCP-25 Gel

Snippet

Sponsor: Xinnate AB | Conditions: Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa | Phase 2 | Status: RECRUITING